atomoxetine hydrochloride has been researched along with Substance-Related Disorders in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (45.16) | 29.6817 |
| 2010's | 16 (51.61) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Arranz, B; Arrojo, M; Becoña, E; Bernardo, M; Castells, X; Cunill, R; Flórez, G; Fonseca, F; Garriga, M; Goikolea, JM; González-Pinto, A; López, A; Sáiz, PA; San, L; Tirado-Muñoz, J; Torrens, M; Zorrilla, I | 1 |
| Chang, Z; D'Onofrio, BM; Gibbons, RD; Hur, K; Lahey, BB; Larsson, H; Lichtenstein, P; Quinn, PD; Rickert, ME; Sjölander, A | 1 |
| Bastiaens, L; Galus, J; Scott, O | 1 |
| Adorjan, K; Erbas, B; Hantschk, I; Karch, S; Koller, G; Martin, G; Plörer, D; Pogarell, O; Winter, C | 1 |
| Benegal, V; Chakraborty, V; Jose, SP; Kandavel, T; Kesavan, M; Narayanaswamy, JC; Sankar, D; Viswanath, B | 1 |
| Dalhoff, KP; Jensen, LS; Pagsberg, AK | 1 |
| Perugi, G; Vannucchi, G | 1 |
| Barkla, XM; McArdle, PA; Newbury-Birch, D | 1 |
| Jillani, S; Kamath, J; Patel, P; Trestman, R | 1 |
| Connemann, BJ; Gahr, M; Schönfeldt-Lecuona, C; Zeiss, R | 1 |
| Sewell, RA; Sofuoglu, M | 1 |
| Dopheide, JA; Pliszka, SR | 1 |
| Akhondzadeh, S; Ghanizadeh, A | 1 |
| Cheetham, SC; Heal, DJ; Smith, SL | 1 |
| Mikulich-Gilbertson, SK; Riggs, PD; Salomonsen-Sautel, S; Thurstone, C | 1 |
| Chakraborty, B; Manniche, PM; Meier, D; Schoedel, KA; Sellers, EM | 1 |
| Spencer, TJ; Wilens, TE | 1 |
| Banaschewski, T; Buitelaar, J; Coghill, D; Danckaerts, M; Dittmann, RW; Döpfner, M; Graham, J; Hamilton, R; Hollis, C; Holtmann, M; Hulpke-Wette, M; Lecendreux, M; Rosenthal, E; Rothenberger, A; Santosh, P; Sergeant, J; Simonoff, E; Sonuga-Barke, E; Steinhausen, HC; Taylor, E; Wong, IC; Zuddas, A | 1 |
| Pérez de los Cobos, J; Pérez, V; Siñol, N; Trujols, J | 1 |
| Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E | 1 |
| Allen, AJ; Bickel, WK; Bymaster, FP; Calligaro, DO; Clarke, DO; Desaiah, D; Durell, TM; Emmerson, PJ; Kallman, MJ; Nisenbaum, ES; Schuh, KJ; Schuh, LM; Trzepacz, PT; Upadhyaya, HP | 1 |
| Arneric, SP; Bain, JN; Buccafusco, JJ; Prendergast, MA; Smith, MA; Terry, AV | 1 |
| Wilens, TE | 1 |
| Bergman, J; Gasior, M; Kallman, MJ; Paronis, CA | 1 |
| Greenfield, B; Hechman, L | 1 |
| Brown, TE; Evans, SW; Gotlieb, EM; Knight, JR; Ross, EC; Shubiner, HH; Wender, EH; Wibbelsman, CJ; Wilens, T; Wolraich, ML | 1 |
| Bettinger, TL; Crismon, ML; Gibson, AP; Patel, NC | 1 |
| Goodman, DW | 1 |
| Bukstein, OG; Crismon, ML; Manos, MJ; Tom-Revzon, C | 1 |
| Allen, AJ; Faries, DE; Jasinski, DR; Moore, RJ; Schuh, LM | 1 |
| Badger, GJ; Bickel, WK; Faries, DE; Heil, SH; Higgins, ST; Holmes, HW; Laws, HF | 1 |
17 review(s) available for atomoxetine hydrochloride and Substance-Related Disorders
| Article | Year |
|---|---|
Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use.
Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cocaine; Comorbidity; Humans; Methylphenidate; Substance-Related Disorders | 2022 |
[Adult attention deficit hyperactivity disorder (ADHD) with comorbid addictive disorder. Therapeutic challenges using the example of a survey of clinical practice].
Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Methylphenidate; Substance-Related Disorders; Surveys and Questionnaires | 2019 |
The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Comorbidity; Humans; Substance-Related Disorders; Treatment Outcome | 2015 |
Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Alcohol Drinking; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Drug Interactions; Humans; Illicit Drugs; Lisdexamfetamine Dimesylate; Methylphenidate; Substance-Related Disorders | 2015 |
Norepinephrine and stimulant addiction.
Topics: Adrenergic Agonists; Amphetamine; Arousal; Atomoxetine Hydrochloride; Attention; Central Nervous System Stimulants; Cocaine; Dopamine; Humans; Methamphetamine; Norepinephrine; Propylamines; Substance-Related Disorders | 2009 |
Attention-deficit-hyperactivity disorder: an update.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Case-Control Studies; Central Nervous System Stimulants; Child; Conduct Disorder; Follow-Up Studies; Humans; Juvenile Delinquency; Longitudinal Studies; Methylphenidate; Patient Compliance; Prescriptions; Prevalence; Propylamines; Substance-Related Disorders; Time Factors; Treatment Outcome; United States | 2009 |
The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Catecholamines; Central Nervous System Stimulants; Dopamine Agents; Humans; Methylphenidate; Propylamines; Stereoisomerism; Substance-Related Disorders | 2009 |
Understanding attention-deficit/hyperactivity disorder from childhood to adulthood.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Humans; Magnetic Resonance Imaging; Mood Disorders; Propylamines; Psychotherapy; Remedial Teaching; Substance-Related Disorders | 2010 |
Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Combined Modality Therapy; Diagnosis, Dual (Psychiatry); Humans; Methylphenidate; Practice Patterns, Physicians'; Propylamines; Psychotherapy; Substance-Related Disorders | 2014 |
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Size; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Clonidine; Dextroamphetamine; Growth Disorders; Guanfacine; Heart Rate; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines; Psychoses, Substance-Induced; Seizures; Sleep Wake Disorders; Substance-Related Disorders; Suicide Prevention; Tic Disorders; Treatment Outcome | 2013 |
A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Addictive; Drug-Seeking Behavior; Humans; Norepinephrine Plasma Membrane Transport Proteins; Propylamines; Protein Binding; Receptors, Neurotransmitter; Substance-Related Disorders | 2013 |
Impact of ADHD and its treatment on substance abuse in adults.
Topics: Adult; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Combined Modality Therapy; Humans; Propylamines; Psychotherapy; Risk Factors; Self Medication; Substance-Related Disorders | 2004 |
Treatment of attention deficit hyperactivity disorder in adults.
Topics: Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Cognitive Behavioral Therapy; Drug Therapy; Drug Therapy, Combination; Expert Testimony; Humans; Nicotine; Propylamines; Substance-Related Disorders | 2005 |
Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications.
Topics: Adolescent; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Case Management; Central Nervous System Stimulants; Child; Clonidine; Comorbidity; Continuity of Patient Care; Family Health; Female; Forecasting; Health Services Accessibility; Humans; Insurance Coverage; Intellectual Disability; Male; Mental Disorders; Patient Compliance; Propylamines; Puberty; Risk; Substance-Related Disorders | 2005 |
Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Humans; Propylamines; Substance-Related Disorders | 2006 |
The consequences of attention-deficit/hyperactivity disorder in adults.
Topics: Achievement; Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Disease Progression; Female; Health Care Costs; Humans; Impulsive Behavior; Male; Mental Disorders; Methylphenidate; Propylamines; Quality of Life; Sex Distribution; Social Adjustment; Substance-Related Disorders | 2007 |
Changes and challenges: managing ADHD in a fast-paced world.
Topics: Algorithms; Antihypertensive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Comorbidity; Drug Delivery Systems; Family; Guanfacine; Humans; Modafinil; Patient Compliance; Prodrugs; Propylamines; Quality of Life; Randomized Controlled Trials as Topic; Substance-Related Disorders; Treatment Outcome | 2007 |
4 trial(s) available for atomoxetine hydrochloride and Substance-Related Disorders
| Article | Year |
|---|---|
Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Checklist; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Interview, Psychological; Male; Motivation; Propylamines; Substance-Related Disorders | 2010 |
Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Atomoxetine Hydrochloride; Attention; Biogenic Monoamines; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Cross-Over Studies; Dextroamphetamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Hemodynamics; Humans; Male; Middle Aged; Propylamines; Psychomotor Performance; Socioeconomic Factors; Substance-Related Disorders; Treatment Outcome; Young Adult | 2010 |
Abuse liability assessment of atomoxetine in a drug-abusing population.
Topics: Adrenergic Uptake Inhibitors; Adult; Arousal; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Cross-Over Studies; Desipramine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methylphenidate; Middle Aged; Pain Measurement; Phentermine; Propylamines; Risk; Substance-Related Disorders | 2008 |
Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users.
Topics: Adolescent; Adult; Analysis of Variance; Atomoxetine Hydrochloride; Blood Pressure; Double-Blind Method; Female; Humans; Least-Squares Analysis; Male; Methylphenidate; Outcome Assessment, Health Care; Propylamines; Psychomotor Performance; Substance-Related Disorders | 2002 |
10 other study(ies) available for atomoxetine hydrochloride and Substance-Related Disorders
| Article | Year |
|---|---|
ADHD Medication and Substance-Related Problems.
Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comorbidity; Female; Humans; Male; Sex Factors; Substance-Related Disorders; United States; Young Adult | 2017 |
Treatment of Adult ADHD without Stimulants: Effectiveness in A Dually Diagnosed Correctional Population.
Topics: Adrenergic Agents; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Comorbidity; Diagnosis, Dual (Psychiatry); Female; Follow-Up Studies; Guanfacine; Humans; Male; Mental Disorders; Nortriptyline; Outcome Assessment, Health Care; Prisoners; Retrospective Studies; Severity of Illness Index; Substance-Related Disorders | 2019 |
The efficacy of atomoxetine as adjunctive treatment for co-morbid substance use disorders and externalizing symptoms.
Topics: Adrenergic Uptake Inhibitors; Adult; Antisocial Personality Disorder; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Female; Humans; Impulsive Behavior; Male; Propylamines; Quality of Life; Substance-Related Disorders; Treatment Outcome | 2013 |
Differences in abuse potential of ADHD drugs measured by contrasting poison centre and therapeutic use data.
Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Denmark; Drug Utilization; Female; Humans; Male; Methylphenidate; Poison Control Centers; Propylamines; Registries; Retrospective Studies; Substance-Related Disorders; Young Adult | 2015 |
Atomoxetine for the Treatment of ADHD in Incarcerated Adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Comorbidity; Humans; Male; Prisoners; Substance-Related Disorders; Treatment Outcome; Young Adult | 2016 |
Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement.
Topics: Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochloride; Australia; Benzhydryl Compounds; Canada; Central Nervous System Stimulants; Drug-Related Side Effects and Adverse Reactions; Excitatory Amino Acid Antagonists; France; Germany; Humans; Italy; Memantine; Methylphenidate; Modafinil; Pharmacovigilance; Spain; Substance-Related Disorders; United Kingdom; United States; Wakefulness-Promoting Agents | 2017 |
Attention deficit hyperactivity disorder in prison.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Prisoners; Propylamines; Substance-Related Disorders | 2009 |
European guidelines on managing adverse effects of medication for ADHD.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Drug Administration Schedule; Drug Dosage Calculations; Drug Tolerance; Drug Utilization Review; Europe; Humans; Monitoring, Physiologic; Propylamines; Risk Assessment; Substance-Related Disorders; Suicide, Attempted | 2011 |
Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential.
Topics: Animals; Atomoxetine Hydrochloride; Attention; Caffeine; Cognition; Cognition Disorders; Color Perception; Female; Macaca mulatta; Macaca nemestrina; Male; Methylphenidate; Morphine; Neuropsychological Tests; Nicotine; Nomifensine; Photic Stimulation; Propylamines; Substance-Related Disorders; Task Performance and Analysis | 2003 |
Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Cocaine; Desipramine; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Female; Infusion Pumps; Macaca mulatta; Methylphenidate; Propylamines; Reinforcement, Psychology; Self Administration; Substance-Related Disorders | 2005 |